fda warning bpc-157 2024 panel votes to place popular peptide on compounding list A step towards expanded patient

FDA approval requires formal clinical trials, safety and efficacy review, labeling approval, and manufacturing validation under a New Drug Application (NDA) or Biologics License Application (BLA)

The fasted cardio stack protocol most commonly described in research communities: Wake up fasted (812 hours post last meal)

Sounds like a Stevens -Johnson Syndrome reaction

My protocol during this period: Retatrutide: 2mg weekly subcutaneous injection (ramped to 4mg by week 10) GHK-Cu: 1mg daily subcutaneous, rotated injection sites Cycle length: 12 weeks on, 4 weeks off Training: 4 days resistance training per week, 8,000 to 10,000 steps daily Protein intake: 130g daily minimum I sourced both from Red Fox Peptides

Read the full study: Therapeutic Potential of Pro-Angiogenic BPC157 is Associated with VEGFR2 Activation and Up-Regulation (J Mol Med 2017)

But the BPC spray has real perks that make it the top choice for many researchers: No Mixing Needed : Injectable peptides come as dry powder